By Shalis Ammons on Apr 3, 2020 4:12:36 AM
RxVision™: Pharmacogenomics Clinical Decision Support System-Part 2
Practices often use a multidisciplinary approach with their patients among multiple physicians and healthcare staff
Patients see multiple physicians outside the practice of the ordering provider, which can lead to difficulties in other providers gaining access to the patients’ PGx test results to all providers
Allowing providers to access patients’ PGxOne™ Plus results within the same practice, even across multiple locations
The ability for physicians to grant access to results with other team members such as nurse practitioners, pharmacists, and other staff
Printing a patient's results is also available in RxVision™, which can subsequently be scanned and integrated into the practice’s EMR and/or shown to the patient during their consultation
Physicians to work in tandem to find the best treatment options for their shared patient
Better treatment decisions when a patient may need to start a new medication
Sharing of test results despite differences in geographic locations
RxVision™ allows providers to view Admera Health’s PGxOne™ Plus test results in an easy-to-use, dynamic format. This post serves as part-two in the RxVision™ blog series, that will touch upon the following topics:
RxVision™ allows healthcare providers to have evidence-based guidance for pharmacogenomics test results from the FDA biomarker list, CPIC, PharmGKB, and FDA approved medication package inserts, which encompasses hundreds of medications
RxVision™ is able to provide longer-term functionality for users with their PGx results—versus other static PGx reports
New medications can be checked against available PGx results for gene-drug interactions
RxVision™ combines drug-drug, drug-food, drug-alcohol, and drug-lab interactions from a medication knowledge-base commonly used in EHRs, along with the patient's pharmacogenomics test results in one central data hub. Thus, eliminating the need to check for drug-drug, drug-food, and drug-lab interactions separately
RxVision™ can be used in preemptive PGx workflows in addition to reactive PGx workflows
How to Get Started with Admera Health:
To get started with Admera Health, click here to fill out the PGxOne™ Plus Test order contact form, or by visiting admerahealth.com/ordernow. You can also reach out via phone at 908-222-0533 or by sending an email to firstname.lastname@example.org.
Follow the steps below to setup your RxVision™ account and access the CDSS platform.
Admera’s PGxOne™ Plus is a pharmacogenomics test that
provides insight for therapeutic decisions.
Over 50 genes | Over 200 variants
Ordering PGxOne™ Plus test sample collections supplies online is a quick and painless process.
About the Author(s):
Dr. Shalis Ammons is the Product Manager for Admera Health's PGxOneTM Plus test. She has earned her doctoral degree in Genetics, Cell Biology and Anatomy at the University of Nebraska Medical Center. After graduation, she transitioned into the commercial side of the life science industry and has been working in marketing for about three years. She can be contacted at email@example.com or 908-222-0533 ext. 3880.